ASP4070

· Astellas Pharma Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASP4070, covering 2020-06-30 to 2024-10-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy [Phase 1]